ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
16 hedge funds and large institutions have $844K invested in Argos Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
Holders
16
Holding in Top 10
1
Calls
$410K
Puts
–
Top Buyers
| 1 | +$316K | |
| 2 | +$66.3K | |
| 3 | +$47.8K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$28.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.1K |
Top Sellers
| 1 | -$157K | |
| 2 | -$96K | |
| 3 | -$24K | |
| 4 |
KeyBank National Association
Cleveland,
Ohio
|
-$18K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$17K |